Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neutropenia 1Neoplasms 1

Interventions

pembrolizumab 305Paclitaxel 205Carboplatin 201Gemcitabine 173Cisplatin 140Docetaxel 138Cyclophosphamide 137Nivolumab 129Bevacizumab 118Injections 112fludarabine 97atezolizumab 91Pemetrexed 91Dexamethasone 90Cetuximab 90Fluorouracil 84Irinotecan 77Rituximab 72Capecitabine 72venetoclax 71Azacitidine 70130-nm albumin-bound paclitaxel 67Leucovorin 65Fulvestrant 58Oxaliplatin 57durvalumab 56Trastuzumab 56Midazolam 55Lenalidomide 55Ipilimumab 55

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × Diet, High-Fat × Clear all
NCT02700360 2016-03-15

Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy Volunteers

Enzychem Lifesciences Corporation

Phase 1 Completed
36 enrolled

Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡